INS and type 1 diabetes mellitus: Following the results of the Diabetes Control and Complications Trial [1] and the start of intensive insulin therapy, clinicians have attempted to help persons with type 1 diabetes (T1D) keep their glucose values as close to the normal range as possible to delay the onset and slow the progression of long-term diabetes complications such as retinopathy, renal disease, neuropathy, and heart disease.